Impact of Advanced Crohn's Disease Therapies on Sleep Quality
Recruiting now
Conditions studied: Crohn Disease (CD)
In brief
The goal of this observational study is to measure changes in sleep quality before and after starting treatment with advance therapy in adult with Crohn disease. The main question it aims to answer is: what is the association between response to therapy and sleeping patterns? Participants who are about to begin advanced treatment will be asked to wear a Fitbit device before end after treatment initiation to monitor sleep patterns and sleep quality, complete a sleep diary and a sleep quality questionnaire. The follow-up period will last 26 weeks, during which disease severity and response to treatment will be assessed.
Key facts
- Study ID
- NCT07649408
- Run by
- Shmuel Kivity, MD
- People needed
- 30
- Starts
- 2025-08-06
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2026-06-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with established diagnosis of Crohn's Disease
- Patients with active inflammation, defined as HBI score ≥ 5 and either CRP>5 or stool calprotectin>250 mcg/gr.
- Patients starting advanced treatment as part of routine medical care (Anti TNFs, vedolizumab, Ustekinumab, IL-23 inhibitors, Jak inhibitors or S1P inhibitors).
You may not qualify if…
- Inability to give informed consent and complete the study protocol.
- Pregnant or lactating women
- Inability or reluctance to follow through with the study protocol, including (but not exclusive) to: questionnaires, wearing the watch while sleeping.
- Patients diagnosed with UC or indeterminate IBD.
- Other sleep disorders Obstructive sleep apnea overactive bladder insomnia shift work disorder restless leg syndrome Periodic limb movement of sleep Narcolepsy
- Use of sleep medication - such as benzodiazepines or cannabis.
- Recent abdominal surgery - previous 4 weeks.
- Severe systemic disease - CVD, Kidney, liver - as jugged by physician's discretion.
- Patients with ileostomy or short bowl syndrome.
Where it is running
- Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center — Tel Aviv, Israel (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.